Fluzoparib in Combination With Apatinib Mesylate for Maintenance Therapy in Stage III-IV Ovarian Cancer

Clinical trial NCT06539091 · NOT_YET_RECRUITING

Trial details

NCT number: NCT06539091
Sponsor: Anhui Provincial Hospital
Status: NOT_YET_RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Epithelial Ovarian Cancer Efficacy Safety Bone Mineral Density Tolerability

Start date: 2024-10-01
Primary completion: 2025-10-01
Enrollment: 51

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.